Skip to Content

'
Gildy V. Babiera, MD, FACS

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1991 New York Medical College, Valhalla, NY, MD, Surgery
1986 Duke University, Durham, NC, BS, Chemistry and Economics

Postgraduate Training

1996-1997 General Surgery Chief Resident, General Surgery, New York University Medical Center, New York, NY
1995-1996 Post-Doctoral Clinical Research Fellowship, Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
1994-1995 Clinical Residency, General Surgery, New York University Medical Center, New York, NY
1992-1993 Clinical Residency, General Surgery, New York University Medical Center, New York, NY
1991-1992 Clinical Internship, General Surgery, New York University Medical Center, New York, NY

Honors and Awards

2011 America's Top Doctors for Cancer, Castle Connolly Top Doctors
2011 Silver Award for Accelerated Partial Breast Irradiation (APBI) Video, National Health Information Awards
2010 America's Top Doctors for Cancer, Castle Connolly Top Doctors
2010 Best Studies of the Month, Senology Oncology and Women's Health
2009 America's Top Doctors for Cancer, Castle Connolly Top Doctors
2008 Outstanding ACOSOG Z1031 Trial Enrollment Award
2007 American Society of Clinical Oncology Foundation Merit Award, American Society of Clinical Oncology Foundation
2007 American Society of Clinical Oncology Foundation Merit Award, May
2007 American Society of Clinical Oncology Foundation Merit Award, September
2006 Who's Who in America
2005-2011 In Recognition of Distinguished Contributions to the Work of the Commission on Cancer, American College of Surgeons,
2005 Best Doctors
1991 Alpha Omega Alpha Honorary Society
1991 American Medical Womens Association Scholarship Award
1991 Cor et Manus Award of Distinction
1991 Janet M. Glasgow Memorial Achievement Citation
1991 New York Medical College Trustee Scholarship Award
1986 Duke Undergraduate Scholarship, Duke University
1986 Graduated Cum Laude, Duke University
1986 Graduated with Distinction in Chemistry, Duke University
1986 Honors Thesis in Calorimetric Studies of Alumni, Duke University

Professional Memberships

American College of Surgeons, Chicago, IL
Member, 1997
Southwest Oncology Group, San Antonio, TX
Group Member, Breast Cancer Committee and Breast Cancer Committee Working Group, 2011-present
Member, 2011

Selected Publications

Peer-Reviewed Original Research Articles
1. Mittendorf EA, Buchholz TA, Tucker SL, Meric-Bernstam F, Kuerer HM, Gonzales-Angulo AM, Bedrosian I, Babiera GV, Yi M, Ross MI, Hortobagyi GN, Hunt KK. Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast conserving therapy. J Clin Oncol, 2012. In Press.
2. Kong AL, Tereffe W, Hunt KK, Yi M, Kang T, Weatherspoon K, Mittendorf EA, Bedrosian I, Hwang RF, Babiera GV, Buchholz TA, Meric-Bernstam F. Impact of internal mammary lymph node drainage identified by perioperative lymphoscintigraphy on outcomes in patients with stage I or III breast cancer. Cancer, 2012. In Press.
3. Kuerer HM, Lari SA, Arun BK, Hu CY, Brewster A, Mittendorf EA, Albarracin CT, Babiera GV, Caudle AS, Wagner JL, Litton JK, Bedrosian I, Meric-Bernstam F, Lucci A, Hunt KK. Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass. Breast Cancer Res Treat. e-Pub 3/2012. PMID: 22392043.
4. Akay CL, Meric-Bernstam F, Hunt KK, Grubbs EG, Bedrosian I, Tucker SL, Kuerer HM, Hoffman KE, Babiera GV, Strom EA, Buchholz TA, Mittendorf EA. Evaluation of the MD anderson prognostic index for local-regional recurrence after breast conserving therapy in patients receiving neoadjuvant chemotherapy. Ann Surg Oncol 19(3):901-7, 3/2012. e-Pub 8/2011. PMID: 21861223.
5. Mittendorf EA, Hunt KK, Boughey JC, Bassett R, Degnim AC, Harrell R, Yi M, Meric-Bernstam F, Ross MI, Babiera GV, Kuerer HM, Hwang RF. Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node. Ann Surg 255(1):109-15, 1/2012. PMID: 22167004.
6. Hatzis C, Sun H, Yao H, Hubbard RE, Meric-Bernstam F, Babiera GV, Wu Y, Pusztai L, Symmans WF. Effects of Tissue Handling on RNA Integrity and Microarray Measurements From Resected Breast Cancers. J Natl Cancer Inst 103(24). e-Pub 10/2011. PMID: 22034635.
7. Caudle AS, Hunt KK, Kuerer HM, Meric-Bernstam F, Lucci A, Bedrosian I, Babiera GV, Hwang RF, Ross MI, Feig BW, Hoffman K, Litton JK, Sahin AA, Yang W, Hortobagyi GN, Buchholz TA, Mittendorf EA. Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 Study: A practice-changing trial. Ann Surg Oncol 18(9):2407-12, 9/2011. PMID: 21327455.
8. Van Leeuwen BL, Rosenkranz KM, Feng LL, Bedrosian I, Hartmann K, Hunt KK, Kuerer HM, Ross M, Singletary SE, Babiera GV, Department of Surgical Oncology, MD Anderson Cancer Center. The effect of under-treatment of breast cancer in women 80 years of age and older. Crit Rev Oncol Hematol 79(3):315-20, 9/2011. e-Pub 7/2010. PMID: 20655242.
9. Sharma R, Rourke LL, Kronowitz SJ, Oh JL, Lucci A, Litton JK, Robb GL, Babiera GV, Mittendorf EA, Hunt KK, Kuerer HM. Management of local-regional recurrence following immediate breast reconstruction in patients with early breast cancer treated without postmastectomy radiotherapy. Plast Reconstr Surg 127(5):1763-72, 5/2011. PMID: 21532405.
10. Yi M, Kronowitz SJ, Meric-Bernstam F, Feig BW, Symmans WF, Lucci A, Ross MI, Babiera GV, Kuerer HM, Hunt KK. Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy. Cancer 117(5):916-24, 3/2011. e-Pub 10/2010. PMID: 20945319.
11. Wagner JL, Warneke CL, Mittendorf EA, Bedrosian I, Babiera GV, Kuerer HM, Hunt KK, Yang W, Sahin AA, Meric-Bernstam F. Delays in primary surgical treatment are not associated with significant tumor size progression in breast cancer patients. Ann Surg 254(1):119-24, 2011. PMID: 21494124.
12. Ellis MJ, Suman VJ, Hoog J, Lin L, Snider J, Prat A, Parker JS, Luo J, Deschryver K, Allred DC, Esserman LJ, Unzeitig GW, Margenthaler J, Babiera GV, Marcom PK, Guenther JM, Watson MA, Leitch M, Hunt K, Olson JA. Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: Clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031. J Clin Oncol 29(17):2342-9, 2011. e-Pub 5/2011. PMID: 21555689.
13. Cohen L, Chen Z, Arun B, Shao Z, Dryden M, Xu L, Le-Petross C, Dogan B, McKenna BJ, Markman M, Babiera G. External qigong therapy for women with breast cancer prior to surgery. Integr Cancer Ther 9(4):348-53, 12/2010. PMID: 21106615.
14. Valero V, Kong AL, Hunt KK, Yi M, Hwang RF, Meric-Bernstam F, Bedrosian I, Ross MI, Babiera GV, Litton JK, Mittendorf EA. Sentinel lymph node dissection is technically feasible in older breast cancer patients. Clin Breast Cancer 10(6):477-82, 12/2010. PMID: 21147692.
15. Sharma R, Bedrosian I, Lucci A, Hwang RF, Rourke LL, Qiao W, Buchholz TA, Kronowitz SJ, Krishnamurthy S, Babiera GV, Gonzalez-Angulo AM, Meric-Bernstam F, Mittendorf EA, Hunt KK, Kuerer HM. Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy. Ann Surg Oncol 17(11):2899-908, 11/2010. e-Pub 5/2010. PMID: 20443145.
16. Kang T, Yi M, Hunt KK, Mittendorf EA, Babiera GV, Kuerer H, Bedrosian I, Hwang RF, Lucci A, Meric-Bernstam F. Does blue dye contribute to success of sentinel node mapping for breast cancer? Ann Surg Oncol 17(Suppl 3):280-5, 10/2010. e-Pub 9/2010. PMID: 20853047.
17. Yi M, Hunt KK, Arun BK, Bedrosian I, Barrera AG, Do KA, Kuerer HM, Babiera GV, Mittendorf EA, Ready K, Litton J, Meric-Bernstam F. Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy. Cancer Prev Res (Phila) 3(8):1026-34, 8/2010. e-Pub 7/2010. PMID: 20647335.
18. Bedrosian I, Babiera GV, Mittendorf EA, Kuerer HM, Pantoja L, Hunt KK, Krishnamurthy S, Meric-Bernstam F. A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients. Cancer 116(11):2543-8, 6/2010. PMID: 20336790.
19. Brown AS, Hunt KK, Shen J, Huo L, Babiera GV, Ross MI, Meric-Bernstam F, Feig BW, Kuerer HM, Boughey JC, Ching CD, Gilcrease MZ. Histologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatment. Cancer 116(12):2878-83, 6/2010. PMID: 20564394.
20. Fearmonti RM, Gayed IW, Kim E, Bedrosian I, Hunt KK, Meric-Bernstam F, Feig B, Ghonimi E, Warneke C, Babiera GV. Intra-individual comparison of lymphatic drainage patterns using subareolar and peritumoral isotope injection for breast cancer. Ann Surg Oncol 17(1):220-7, 1/2010. e-Pub 8/2009. PMID: 19680729.
21. Fearmonti RM, Batista LI, Meric-Bernstam F, Bedrosian I, Kuerer HM, Hunt KK, Eva Singletary S, Babiera GV. False negative rate of sentinel lymph node biopsy in multicentric and multifocal breast cancers may be higher in cases with large additive tumor burden. Breast J 15(6):645-8, Nov-Dec, 11/2009. e-Pub 9/2009. PMID: 19735388.
22. Hunt KK, Yi M, Mittendorf EA, Guerrero C, Babiera GV, Bedrosian I, Hwang RF, Kuerer HM, Ross MI, Meric-Bernstam F. Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients. Ann Surg 250(4):558-66, 10/2009. e-Pub 8/2009. PMID: 19730235.
23. Wagner J, Boughey JC, Garrett B, Babiera G, Kuerer H, Meric-Bernstam F, Singletary E, Hunt KK, Middleton LP, Bedrosian I. Margin assessment after neoadjuvant chemotherapy in invasive lobular cancer. Am J Surg 198(3):387-91, 9/2009. e-Pub 4/2009.
24. Boughey JC, Wagner J, Garrett BJ, Harker L, Middleton LP, Babiera GV, Meric-Bernstam F, Lucci A, Hunt KK, Bedrosian I. Neoadjuvant chemotherapy in invasive lobular carcinoma may not improve rates of breast conservation. Ann Surg Oncol 16(6):1606-11, 6/2009. e-Pub 3/2009. PMID: 19280264.
25. Krishnamurthy S, Meric-Bernstam F, Lucci A, Hwang RF, Kuerer HM, Babiera G, Ames FC, Feig BW, Ross MI, Singletary E, Hunt KK, Bedrosian I. A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer. Cancer 115(7):1555-62, 4/2009.
26. Yi M, Meric-Bernstam F, Middleton LP, Arun BK, Bedrosian I, Babiera GV, Hwang RF, Kuerer HM, Yang W, Hunt KK. Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy. Cancer 115(5):962-71, 3/2009. PMID: 19172584.
27. Kuerer HM, Albarracin CT, Yang WT, Cardiff RD, Brewster AM, Symmans WF, Hylton NM, Middleton LP, Krishnamurthy S, Perkins GH, Babiera G, Edgerton ME, Czerniecki BJ, Arun BK, Hortobagyi GN. Ductal carcinoma in situ: state of the science and roadmap to advance the field. J Clin Oncol 27(2):279-88, 1/2009.
28. Mittendorf EA, Sahin AA, Tucker SL, Meric-Bernstam F, Yi M, Nayeemuddin KM, Babiera GV, Ross MI, Feig BW, Kuerer HM, Hunt KK. Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients. Ann Surg Oncol 15(12):3369-77, 12/2008.
29. Yi M, Meric-Bernstam F, Akins JS, Hwang RF, Lucci A, Kuerer HM, Babiera GV, Gilcrease MZ, Hunt KK. How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer? Cancer 113(1):30-37, 7/2008.
30. Rao R, Feng L, Kuerer HM, Singletary SE, Bedrosian I, Hunt KK, Ross MI, Hortobagyi GN, Feig BW, Ames FC, Babiera GV. Timing of surgical intervention for the intact primary in stage IV breast cancer patients. Ann Surg Oncol 15(6):1696-702, 6/2008. e-Pub 3/2008. PMID: 18357493.
31. Badgwell BD, Giordano SH, Duan Z, Fang S, Bedrosian I, Kuerer HM, Singletary SE, Hunt KK, Hortobagyi GN, Babiera G. Mammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol 26(15):2482-8, 5/2008. e-Pub 4/2008. PMID: 18427152.
32. Boughey JC, Cormier JN, Xing Y, Hunt KK, Meric-Bernstam F, Babiera GV, Ross MI, Kuerer HM, Singletary SE, Bedrosian I. Decision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomy. Cancer 110(11):2542-2550, 12/2007.
33. Vo T, Xing Y, Meric-Bernstam F, Mirza N, Vlastos G, Symmans WF, Perkins GH, Buchholz TA, Babiera GV, Kuerer HM, Bedrosian I, Akins JS, Hunt KK. Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy. Am J Surg 194(4):527-31, 10/2007. PMID: 17826073.
34. Boughey JC, Middleton LP, Harker L, Garrett B, Fornage B, Hunt KK, Babiera GV, Dempsey P, Bedrosian I. Utility of ultrasound and fine-needle aspiration biopsy of the axilla in the assessment of invasive lobular carcinoma of the breast. Am J Surg 194(4):450-5, 10/2007. PMID: 17826054.
35. Hwang RF, Gonzalez-Angulo AM, Yi M, Buchholz TA, Meric-Bernstam F, Kuerer HM, Babiera GV, Tereffe W, Liu DD, Hunt KK. Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer 110(4):723-30, 8/2007. PMID: 17587208.
36. Shen J, Gilcrease MZ, Babiera GV, Ross MI, Meric-Bernstam F, Feig BW, Kuerer HM, Francis A, Ames FC, Hunt KK. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer 109(7):1255-63, 4/2007. PMID: 17330229.
37. Cabioglu N, Hunt KK, Sahin AA, Kuerer HM, Babiera GV, Singletary SE, Whitman GJ, Ross MI, Ames FC, Feig BW, Buchholz TA, Meric-Bernstam F. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery. Ann Surg Oncol 14(4):1458-71, 4/2007. e-Pub 1/2007. PMID: 17260108.
38. Babiera GV, Rao R, Feng L, Meric-Bernstam F, Kuerer HM, Singletary SE, Hunt KK, Ross MI, Gwyn KM, Feig BW, Ames FC, Hortobagyi GN. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol 13:776-82, 6/2006. PMID: 16614878.
39. Le-Petross H, Babiera GV, Gong Y. Inflammatory breast cancer (IBC): defining breast magnetic resonance imaging (MRI) features. J Clin Oncol. Submitted.
40. Tereffe W, Lang JE, Rao R, Feng L, Yu TK, Oh JL, Woodward WA, Hunt KK, Hortobagyi GN, Babiera GV. Local radiotherapy improves survival in stage IV breast cancer patients who undergo surgical resection of the primary tumor. Int J Rad Oncol. Submitted.
41. Bloom E, Babiera G, Kirsner S, Kisling K, Mason B, Ballo M, Nelson C, Munsell M, Gifford K. Minimal toxicity with single entry partial breast brachytherapy through optimized treatment planning and catheter choice: The MD Anderson Experience. Red Journal, 2012. Submitted.
42. Kuerer HM, Buzdar A, Mittendorf EA, Esteva FJ, Lucci A, Vence LM, Radvanyi L, Hunt KK, Babiera GV, Meric-Bernstam F, Bedrosian I,Hwang RF, and Symmans WF. Preoperative trastuzumab for ductal carcinoma in situ of the breast. Clin Cancer Res. Submitted.
43. Lang JE, Tereffe W, Rao Roshni, Feng L, Meric-Bernstam F, Bedrosian I, Kuerer HM, Singletary SE, Hunt KK, Hortobagyi GN, Babiera GV. Primary tumor extirpation in breast cancer patients who present with Stage IV disease is associated with improved survival. Ann Surg Oncol. Submitted.
44. Skinner H, Strom E, Motwani S, Woodward W, Green M, Babiera G, Booser D, Meric-Bernstam F, Yu K, Buchholz T. Radiation dose escalation therapy for loco-regional recurrence after mastectomy in radiation naive patients. Red Journal. Submitted.
45. Dick J, Tereffe W, Olanrewaju A, Babiera GV, Buchholz T, Salehpour M. Using an implantable MOSFET dosimeter to determine variations in predicted and actual in situ radiation dose measurements in breast cancer patients. Am J Clin Oncol. Submitted.

Invited Articles
1. Babiera GV. Breast - Better Guidelines for Women Over 80. M.D. Anderson Annual Report 2007 - 2008, 3/2009.
2. Ching CD, Babiera GV. Mammography a viable option for healthy women as they age. ACP Internist, 1/2009.
3. Babiera GV. Metastatic breast cancer: a paradigm shift toward a more aggressive approach. Cancer J 15(1):78, Jan-Feb, 1/2009. PMID: 19197179.
4. Lang JE, Babiera GV. Locoregional resection in stage IV breast cancer: Tumor biology, molecular and clinical perspectives. Surg Clin N Am 87(2):527-538, 4/2007. PMID: 17498542.
5. Babiera GV. Surgical considerations for breast conserving therapy in patients undergoing neoadjuvant chemotherapy for early-stage breast cancer. Br Ca Online 8(2), www.bco.org, 2005.

Editorials
1. Güth U, Huang DJ, Dirnhofer S, Rochlitz C, Wight E. Distant Metastatic Breast Cancer as an Incurable Disease: A Tenet with a Need for Revision. The Cancer Journal 15(1):81-6, 5/2009.
2. Babiera GV. Surgery of the intact primary tumor for patients presenting with metastatic breast cancer: Palliation or cure? Breast Diseases: A Year Book Quarterly 17(3):217-218, 2006.

Abstracts
1. Bloom ES, Gifford K, Kirsner S, Nelson C, Mason BS, Bejarano M, Hoover S, Hunt K, Bedrosian I, Babiera G. The Importance of Multidisciplinary Collaboration Between Surgeon and Radiation Oncologist for Optimal and Placement of Single-entry Brachytherapy Catheters for Accelerated Partial Breast Irradiation. American Society of Breast Surgeons 13th Annual Meeting, Phoenix, AZ, May 2-6, 2012. Submitted.

Book Chapters
1. Gilcrease MZ, Babiera GV, Hennessy BT, Woodward WA. Metaplastic Carcinoma of the Breast. In: Advanced Therapy of Breast Disease, 3rd. Ed(s) Babiera GV, Skoracki RJ, Esteva FJ. People's Medical Publishing House: Shelton, Connecticut, 1119-32, 2012.
2. Caudle AS, Babiera GV. Primary Tumor Extirpation in Stage IV Disease: Surgical Considerations. In: Advanced Therapy of Breast Disease, 3rd. Ed(s) Babiera GV, Skoracki RJ, Esteva FJ. People's Medical Publishing House: Shelton, Connecticut, 1001-08, 2012.
3. Rao R, Babiera GV. Selection Criteria for Breast Conservation. In: Advanced Therapy of Breast Disease, 3rd. Ed(s) Babiera GV, Skoracki RJ, Esteva FJ. People's Medical Publishing House: Shelton, Connecticut, 511-25, 2012.
4. Babiera GV, Khan SA. Treatment of Stage IV Breast Cancer with Intact Primary - A Case for Resection? In: Current Breast Cancer Reports. Springer: Philadelphia, PA, 2012.
5. Negron-Gonzalez V, Cristofanilli M, Babiera GV. Inflammatory Breast Cancer. In: Kuerer's Breast Surgical Oncology. McGraw-Hill: USA, 927-35, 2010.
6. Babiera GV, Caudle AS. Management of Recurrent and Disseminated Breast Cancer. In: Cameron's Current Surgical Therapy, 10th. Ed(s) Cameron JL, Cameron AM. Elsevier Saunders: Philadelphia, PA, 952-56, 2010.
7. Mendez J, Singletary SE, Babiera GV. Surgery in Patients with Stage IV Metastatic Breast Cancer. In: Kuerer’s Breast Surgical Oncology. McGraw-Hill: USA, 753-8, 2010.
8. Al-Rafaie W, Middleton L, Strom EA, Babiera GV. Advanced Therapy in Surgical Oncology. In: Surgical management of axillary metastases from occult primary breast cancer. Ed(s) Pollock RE, Ross MI, Curley SA, Perrier ND. BC Decker Inc. Canada, 543-48, 2008.
9. Hennessy BT, Gilcrease MZ, Babiera GV, Yang W, Valero V, Hortobagyi GN. Carcinosarcoma of the breast. In: Textbook of Uncommon Cancers, 2006.
10. Zager J, Babiera GV. Invasive Ductal Carcinoma. In: The M. D. Anderson Surgical Oncology Handbook. Lippincott Williams and Wilkins, 2005.
11. Babiera GV. Breast Conservation Therapy: Selection Criteria. In: Advanced Therapy of Breast Disease. BC Decker Inc., 330-340, 2004.
12. Chagpar A, Babiera GV. Mastitis and Breast Abscess. In: Problems in General Surgery. 20(4), 2003.
13. Scaife C, Babiera GV. The approach to breast cancer. In: Case Files in General Surgery. McGraw-Hill and Lange Medical Books, 2003.
14. Scaife C, Babiera GV. The approach to the high-risk patient with breast cancer. In: Case Files in General Surgery. McGraw-Hill and Lange Medical Books, 2003.

Books (edited and written)
1. Babiera, GV. Ed(s) Esteva F, Skoracki R. Advanced Therapy of Breast Disease, 3rd. People’s Medical Publishing House - USA: Connecticut, 2012.

Letters to the Editor
1. Rao R, Babiera GV. Author reply: Surgery in stage iv breast cancer patients: continued controversy. Ann Surg Oncol 16(5):1441, 5/2009.
2. Raut CP, Daley D, Hunt KK, Akins J, Ross MI, Singletary SE, Marshall GD, Meric-Bernstam F, Babiera GV, Feig BW, Ames FC, Kuerer HM. Anaphylactoid Reactions to Isosulfan Blue Dye during Breast Cancer Lymphatic Mapping in Patients Given Preoperative Prophylaxis. J Clin Oncol 22:567-8, 2004.
 

Other
1. Invited Brief Commentary.

SABCS - Brachytherapy Study Accelerated Partial Breast Irradiation

Surgery News, 2011

Babiera GV, Kuerer HM

.

Last updated: 4/18/2012